Windlas Biotech IPO Closed
Already have an account? Apply now
About Windlas Biotech
Windlas Biotech Limited is launching its IPO. The public offering comprises a fresh issue of equity shares aggregating up to Rs. 165 crores and an offer for sale of 51.4 lakh equity shares from selling shareholders.
About the company:
Windlas Biotech is among the top five players in the domestic pharmaceutical formulations CDMO (Contract Development and Manufacturing Organization) industry in terms of revenue. The company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing, and commercial manufacturing of generic products. In addition to providing services and products in the CDMO market, the company also sells its products in the trade generics and OTC markets as well as export generic products to several countries.
Financial Snapshot
| Financial Year Ended | Revenue (₹ Crores) | PAT (₹ Crores) | EPS (₹) |
| March 2019 | 311.53 | 63.82 | 37.65 |
| March 2020 | 331.34 | 16.21 | 8.9 |
| March 2021 | 430.70 | 15.57 | 8.7 |
How do I apply for the Windlas Biotech IPO?
You can apply for the Windlas Biotech IPO using any supported UPI app by following two steps:
- Enter your bid on Console
- Accept UPI mandate on your phone
On acceptance of the mandate, the bid amount will get blocked in your bank account. Click here to learn more.